Are You Sleep Savvy? Test Your Insomnia Knowledge!

A study of 149 patients showed that OSAMS, a morphology-based screening tool, offers better detection of severe sleep apnea than commonly used questionnaires.

Data show patients with poor sleep health and the high biomarker scores for renal function were nearly six times more likely to develop MASLD.

With 90% of OSA cases going undiagnosed, the high cost of in-lab studies remains a significant barrier. A new FDA-approved, noninvasive treatment option could change that.

New treatments, including oral medications and GLP-1 therapies, are expanding options beyond CPAP for sleep apnea.

A study of more than 2.8 million people with sleep apnea suggests using CPAP instead of surgery was linked to increased risk of motor vehicle accidents.

Most patients undergoing bariatric surgery have sleep apnea, with poor sleep quality tied to age, sex and BMI.

The affordability and accessibility of new diagnostic tools empower patients to take a proactive role in their health management.

A study of 149 patients showed that OSAMS, a morphology-based screening tool, offers better detection of severe sleep apnea than commonly used questionnaires.

Data show patients with poor sleep health and the high biomarker scores for renal function were nearly six times more likely to develop MASLD.